Caitong International Asset Management Co., LTD Atea Pharmaceuticals, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 479 shares of AVIR stock, worth $1,508. This represents 0.0% of its overall portfolio holdings.
Number of Shares
479
Previous 479
-0.0%
Holding current value
$1,508
Previous $1.61 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AVIR
# of Institutions
112Shares Held
50.9MCall Options Held
900Put Options Held
63K-
Black Rock Inc. New York, NY9.12MShares$28.7 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$24 Million15.83% of portfolio
-
Tang Capital Management LLC San Diego, CA4.79MShares$15.1 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.67MShares$14.7 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.34MShares$10.5 Million0.52% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $262M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...